Nahoko Sato

8PUBLICATIONS
100CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyGenome structure and regulationMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 22, 2026
Blockade of Tumor-Intrinsic TGFβ Signaling Drives Hyperprogression in Small Cell Lung Cancer.

|Mar 17, 2026
Durvalumab and cediranib with and without olaparib in recurrent ovarian cancer: a phase II proof-of-concept study.

Junya Tabata, Tzu-Ting Huang, Elena Giudice

|Jan 08, 2026
SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).

AeRang Kim, Karla V Ballman, Pamela L Wolters

|Dec 19, 2025
Topoisomerase III-beta protects from immune dysregulation and tumorigenesis.

Md Rasel Al Mahmud, Simone Andrea Baechler, Anjali Dhall

|Dec 08, 2025
A Phase II Pilot Study of Anti-PD-L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple-Negative Breast Cancer With or Without Germline BRCA Mutation.

Takeo Fujii, Ashley Cimino-Mathews, Stanley Lipkowitz

|Nov 19, 2025
Phase II proof-of-concept study of durvalumab and cediranib with and without olaparib in recurrent ovarian cancer.

Jung-Min Lee, Junya Tabata, Tzu-Ting Huang

Pageof 2

Frequent Collaborators

7 joint publications

Shraddha Rastogi

4 joint publications

Bernadette Redd

4 joint publications

Min-Jung Lee

3 joint publications

Elena Giudice